nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—Dry cough—Hydrochlorothiazide—nephrolithiasis	0.0665	0.0665	CcSEcCtD
Posaconazole—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0246	0.0246	CcSEcCtD
Posaconazole—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0223	CcSEcCtD
Posaconazole—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0216	CcSEcCtD
Posaconazole—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.016	0.016	CcSEcCtD
Posaconazole—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0152	CcSEcCtD
Posaconazole—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0143	CcSEcCtD
Posaconazole—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Posaconazole—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Posaconazole—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Posaconazole—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Posaconazole—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Posaconazole—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Posaconazole—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Posaconazole—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Posaconazole—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Posaconazole—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Posaconazole—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Posaconazole—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Posaconazole—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Posaconazole—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Posaconazole—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00971	0.00971	CcSEcCtD
Posaconazole—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00966	0.00966	CcSEcCtD
Posaconazole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0094	0.0094	CcSEcCtD
Posaconazole—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0093	0.0093	CcSEcCtD
Posaconazole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00863	0.00863	CcSEcCtD
Posaconazole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00842	0.00842	CcSEcCtD
Posaconazole—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00835	0.00835	CcSEcCtD
Posaconazole—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0082	CcSEcCtD
Posaconazole—Injury—Hydrochlorothiazide—nephrolithiasis	0.00812	0.00812	CcSEcCtD
Posaconazole—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00805	0.00805	CcSEcCtD
Posaconazole—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00798	0.00798	CcSEcCtD
Posaconazole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00795	0.00795	CcSEcCtD
Posaconazole—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00791	0.00791	CcSEcCtD
Posaconazole—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00788	0.00788	CcSEcCtD
Posaconazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00785	CcSEcCtD
Posaconazole—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00785	CcSEcCtD
Posaconazole—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00775	0.00775	CcSEcCtD
Posaconazole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0075	CcSEcCtD
Posaconazole—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00747	0.00747	CcSEcCtD
Posaconazole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00747	0.00747	CcSEcCtD
Posaconazole—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00741	CcSEcCtD
Posaconazole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00735	CcSEcCtD
Posaconazole—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00735	CcSEcCtD
Posaconazole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00721	0.00721	CcSEcCtD
Posaconazole—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00707	0.00707	CcSEcCtD
Posaconazole—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Posaconazole—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.007	0.007	CcSEcCtD
Posaconazole—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00689	0.00689	CcSEcCtD
Posaconazole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00684	CcSEcCtD
Posaconazole—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00682	0.00682	CcSEcCtD
Posaconazole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00682	0.00682	CcSEcCtD
Posaconazole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0068	CcSEcCtD
Posaconazole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00675	0.00675	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00672	CcSEcCtD
Posaconazole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00672	CcSEcCtD
Posaconazole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00661	0.00661	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00659	0.00659	CcSEcCtD
Posaconazole—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00659	0.00659	CcSEcCtD
Posaconazole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0065	CcSEcCtD
Posaconazole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00645	CcSEcCtD
Posaconazole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00633	CcSEcCtD
Posaconazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00603	CcSEcCtD
Posaconazole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00603	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.006	0.006	CcSEcCtD
Posaconazole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00596	0.00596	CcSEcCtD
Posaconazole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00587	CcSEcCtD
Posaconazole—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00582	CcSEcCtD
Posaconazole—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00579	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00571	0.00571	CcSEcCtD
Posaconazole—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00567	0.00567	CcSEcCtD
Posaconazole—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00566	CcSEcCtD
Posaconazole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00564	CcSEcCtD
Posaconazole—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00564	CcSEcCtD
Posaconazole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00561	0.00561	CcSEcCtD
Posaconazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00559	CcSEcCtD
Posaconazole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00559	CcSEcCtD
Posaconazole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00549	CcSEcCtD
Posaconazole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00543	CcSEcCtD
Posaconazole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0054	CcSEcCtD
Posaconazole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00537	CcSEcCtD
Posaconazole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00526	CcSEcCtD
Posaconazole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00518	CcSEcCtD
Posaconazole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00517	CcSEcCtD
Posaconazole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00514	CcSEcCtD
Posaconazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00513	CcSEcCtD
Posaconazole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00509	CcSEcCtD
Posaconazole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00488	0.00488	CcSEcCtD
Posaconazole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00482	0.00482	CcSEcCtD
Posaconazole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00479	CcSEcCtD
Posaconazole—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00461	CcSEcCtD
Posaconazole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00456	0.00456	CcSEcCtD
Posaconazole—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0045	0.0045	CcSEcCtD
Posaconazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00443	CcSEcCtD
Posaconazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0044	0.0044	CcSEcCtD
Posaconazole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00435	CcSEcCtD
Posaconazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00432	CcSEcCtD
Posaconazole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00424	CcSEcCtD
Posaconazole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00421	CcSEcCtD
Posaconazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00417	0.00417	CcSEcCtD
Posaconazole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00416	CcSEcCtD
Posaconazole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00413	CcSEcCtD
Posaconazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00406	CcSEcCtD
Posaconazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00404	CcSEcCtD
Posaconazole—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00403	CcSEcCtD
Posaconazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00403	CcSEcCtD
Posaconazole—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00395	CcSEcCtD
Posaconazole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00392	CcSEcCtD
Posaconazole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00383	CcSEcCtD
Posaconazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00383	CcSEcCtD
Posaconazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00383	CcSEcCtD
Posaconazole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00382	CcSEcCtD
Posaconazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00378	CcSEcCtD
Posaconazole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00374	CcSEcCtD
Posaconazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0037	0.0037	CcSEcCtD
Posaconazole—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00367	CcSEcCtD
Posaconazole—Shock—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00361	CcSEcCtD
Posaconazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00359	CcSEcCtD
Posaconazole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00358	CcSEcCtD
Posaconazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00355	CcSEcCtD
Posaconazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0035	CcSEcCtD
Posaconazole—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00343	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00334	CcSEcCtD
Posaconazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00332	CcSEcCtD
Posaconazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0033	0.0033	CcSEcCtD
Posaconazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00327	CcSEcCtD
Posaconazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00326	CcSEcCtD
Posaconazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00323	CcSEcCtD
Posaconazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00319	CcSEcCtD
Posaconazole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00316	CcSEcCtD
Posaconazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00314	CcSEcCtD
Posaconazole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00314	CcSEcCtD
Posaconazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00302	CcSEcCtD
Posaconazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.003	0.003	CcSEcCtD
Posaconazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00292	CcSEcCtD
Posaconazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0029	CcSEcCtD
Posaconazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0029	CcSEcCtD
Posaconazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0027	0.0027	CcSEcCtD
Posaconazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00263	CcSEcCtD
Posaconazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0026	0.0026	CcSEcCtD
Posaconazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00251	CcSEcCtD
Posaconazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00243	CcSEcCtD
Posaconazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00233	CcSEcCtD
Posaconazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00231	CcSEcCtD
Posaconazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00231	CcSEcCtD
Posaconazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.0023	0.0023	CcSEcCtD
Posaconazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00218	CcSEcCtD
